# Study of TAK-228 (MLN0128) in Soft Tissue Sarcomas

> **NCT02987959** · PHASE2 · TERMINATED · sponsor: **Fox Chase Cancer Center** · enrollment: 6 (actual)

## Conditions studied

- Soft-tissue Sarcoma

## Interventions

- **DRUG:** TAK-228

## Key facts

- **NCT ID:** NCT02987959
- **Lead sponsor:** Fox Chase Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2017-02-21
- **Primary completion:** 2019-01-30
- **Final completion:** 2020-07-24
- **Target enrollment:** 6 (ACTUAL)
- **Why stopped:** Closed to accrual due to Funding Sponsor withdrawing support due to low accrual
- **Last updated:** 2022-10-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02987959

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02987959, "Study of TAK-228 (MLN0128) in Soft Tissue Sarcomas". Retrieved via AI Analytics 2026-08-03 from https://api.ai-analytics.org/clinical/NCT02987959. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*